Skip to content

Clinical trials

Pancreatic Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: Norway Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20112
20122
20141
20151
20161
20181
20191
20211
20222
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting4
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital2
Active Biotech AB1
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Daiichi Sankyo1
Eli Lilly and Company1
Flemming Forsberg1
Helse Stavanger HF1
Helsinki University Central Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms21
Carcinoma, Non-Small-Cell Lung3
Biliary Tract Neoplasms2
Carcinoma2
Melanoma2
Adenocarcinoma1
Adenoma1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Renal Cell1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.